All Type of News
JW Pharmaceutical receives official safety certification of ‘Livalo’ in treating diabetes in 10 countries
Hyperlipidemia treatment ‘Livalo(generic name: pitavastatin)’ was once officially certified that it has no symptoms causing diabetes from another country.
JW Pharmaceutical(CEO Jae-Kwang Jeon & Young-Sup Shin) announ...
No. 1 & 2 pharmaceutical companies Yuhan Corporation and GC Pharm gather for new drug development
Two of the largest pharmaceutical companies will take barnstorming sessions to develop orphan drugs.
GC Pharm and Yuhan Corporation announced on the 19th that they signed a memorandum of understanding to jointly deve...
US FDA starts to assess Celltrion’s Herzuma approval
Celltrion will resume the U.S. approval acquisition process as completing submission of additional documents to the FDA for ‘Herzuma,’ an antibody biosimilar for breast cancer.
Celltrion announced the company officia...
MFDS supports rapid development of incrementally modified drugs and first generics
The Ministry of Food and Drug Safety will extensively support drug patent information to encourage development of competitive products, such as incrementally modified drugs and first generics.
The Patent Linkage Sys...
31 innovative pharma certificate to be extended until 2021 including CJ HealthCare
31 innovative pharmaceutical companies whose certificate will be expiring soon will keep the status for 3 more years by 2021.
The new 3 year will be applied by the new and stricter ethical and rebate standards in the...
Kolon Life Science acquire approval of tumor killing virus therapy
Kolon Life Science(CEO Woo-Seok Lee) announced on the 15th that the company acquired a patent of the poxvirus promoter,’ the company’s next pipeline that increases efficacy of the oncolytic virus treatment(also known ...
“Support Project for the Right Use of Drugs is to prevent health care providers from ab/misuse of drugs”
As the Korean Medical Association brought up the ‘infringement of the right to prescribe medicines’ in regards to the National Health Insurance Service(NHIS) and Korea Pharmaceutical Association’s ‘Support Project for...
Huons & KRICT’s co-development agreement of targeted liver disease therapy
Huons(CEO Ki-Ahn Um) will take joint development of a new drug for liver diseases with the Korea Research Institute of Chemical Technology.
Huons and the Korea Research Institute of Chemical Technology(KRICT) announc...
MOHW hits ‘green light’ on discussing about health care costs for safe management of high-risk drugs
The discussion about health care costs for safe management of high-risk drugs for pharmacists working at medical institutes has been positively reviewed.
Secretary Seung-Ryung Hong at the Ministry of Health and Welfa...
MFDS carries out mutually cooperative system for GMP with ASEAN and Latin American countries
In order to support Korean pharmaceutical companies to enter overseas markets, the government will be active in establishing a mutually cooperative system in the drug GMP field with ASEAN and Latin American countries....
